Ceo & Founder
Currenthttps://icardio.aiiCardio.ai is a Los Angeles-based deep learning startup automating the interpretation of heart ultrasounds. iCardio.ai’s core AI products are trained on over +200 million images. iCardio.ai has teamed with some of the largest Ultrasound vendors, including Abbott, Butterfly Network, and UltraLinQ, to deliver its technology to clinicians around the globe. In February of 2024, iCardio.ai received Breakthrough Designation by the FDA for its automated capability to detect Aortic Stenosis from b-mode ultrasound imagery. In October of 2024, iCardio.ai received 510(k) FDA Clearance for its AI system for automated echocardiography.